14
Views
6
CrossRef citations to date
0
Altmetric
Case Report

Spontaneous pneumothorax in Wegener's granulomatosis: a case report

, , , , &
Pages 76-80 | Received 01 May 2007, Accepted 07 Sep 2007, Published online: 02 Jan 2014

References

  • Leavitt RY, Fauci AS, Bloch D, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990;33:1101–7.
  • Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–92.
  • Stone JH, Hofman GS. Wegener's granulomatosis and lympho-matoid granulomatosis. In: Hoschberg MC, Silman AJ, Smolen JS, et al. (eds) Rheumatology, 3rd ed. St. Louis: Mosby; 2003. pp. 1635–48.
  • Abdou N, Kullman G, Hoffman GS, Sharp GC, Specks U, McDonald T, et al. Wegener's granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s. J Rheumatol. 2002;29: 309–16.
  • Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116:488–98.
  • Fauci AS, Haynes BF, Katz P, Wolff SM, et al. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983;98:76–85.
  • Koldingsnes W, Nossent H. Predictors of survival and organ damage in Wegener's granulomatosis. Rheumatology. 2002; 41:572–81.
  • Delevaux I, Khellaf M, Andre M, Michel JL, Piette JC, Aumaitre 0. Spontaneous pneumothorax in Wegener's granulomatosis. Chest. 2005;128:3074–5.
  • Epstein DM, Gefter WB, Miller WT Gohel V, Bonavita JA. Spontaneous pneumothorax: an uncommon manifestation of Wegener's granulomatosis. Radiology. 1980;135:327–8.
  • Jaspan T, Davison AM, Walker WC. Spontaneous pneumothorax in Wegener's granulomatosis. Thorax. 1982;37:774–5.
  • Wolffenbuttel BH, Weber RF, Kho GS. Pyopneumothorax: a rare complication of Wegener's granulomatosis. Eur J Respir Dis. 1985;67:223–7.
  • Ogawa M, Azemoto R, Makino Y, Mori Y, Ueda S, Wakashin M, et al. Pneumothorax in a patient with Wegener's granulomatosis during treatment with immunosuppressive agents. J Intern Med. 1991;229:189–92.
  • Bulbul Y, Ozlu T, Oztuna F. Wegener's granulomatosis with parotid gland involvement, pneumothorax. Med Princ Pract. 2003;12:133–7.
  • Ates A, Karaaslan Y, Yildiz G, Gunesen 0, Han S. A case of Wegener's granulomatosis complicated with hydropneumotho-rax. J Clin Rheumatol. 2006;12:264–5.
  • Mies Richie A, Francis ML. Diagnostic approach to polyarticular joint pain. Am Fam Physician. 2003;68:1151–60.
  • Pavelka K Jr, Dostal C, Rossmann P, Kraus H, Matousovic K, Vrabec J. Wegener's granulomatosis with bilateral necrotizing scleritis, polyarthritis and renal failure efficiently treated with immunosuppressive therapy. Clin Rheumatol. 1986;5:112–7.
  • El-Gabalawy HS, Duray P, Goldbach-Mansky R. Evaluating patients with arthritis of recent onset: studies in pathogenesis and prognosis. JAMA. 2000;284:2368–73.
  • Brazzelli V, Vassallo C, Baldini F, Ravelli A, Martini A, Borroni G. Wegener's granulomatosis in a child: cutaneous findings as the presenting signs. Pediatr Dermatol. 1999;16:277–80.
  • Barksdale SK, Hallahan CW, Kerr GS, Fauci AS, Stem JB, et al. Cutaneous pathology in Wegener's granulomatosis. A clinico-pathologic study of 75 biopsies in 46 patients. Am J Surg Pathol. 1995;19:161–72.
  • Stein CM. Immunoregulatory drugs. In: Ruddy S, Harris ED (eds) Kelley's textbook of rheumatology. 6th edn., Philadelphia: WB Saunders Company, 2001. pp. 879–98.
  • Guillevin L, Cordier JF, Lhote F, Cohen P, Janousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum. 1997;40:2187–98.
  • Hoffman GS, Leavitt RY, Fleisher TA, Minor JR, Fauci AS. Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med. 1990;89:403–10.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.